Milnacipran Hydrochloride Tablet
Product Images NDC 33342-369

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Milnacipran Hydrochloride (NDC 33342-369). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

879 (Milnacipran 100 60s)

Milnacipran Hydrochloride 100 mg film-coated tablets packaging label from Macleods Pharmaceuticals Limited. The label includes the NDC number 33342-372-09, directions to keep out of reach of children, storage instructions at 20° to 25°C, and that the product is manufactured in India. The package contains 60 tablets and is labeled for prescription use only. Manufacturer details include Macleods Pharma USA, Inc., Princeton, NJ.*

FDA Label Image

545 (Milnacipran 12 5 60s)

Label for Milnacipran Hydrochloride Tablets 12.5 mg by Macleods Pharmaceuticals Limited. The label includes the NDC number 33342-369-09, dosage strength of 12.5 mg per tablet, packaging of 60 tablets, and storage instructions. It states the product is manufactured for Macleods Pharma USA, Inc. in Princeton, NJ, and manufactured in India.*

FDA Label Image

789 (Milnacipran 25 60s)

Milnacipran Hydrochloride Tablets 25 mg film-coated oral tablets label from Macleods Pharmaceuticals Ltd. The label shows NDC 33342-370-09, a 60 tablet package for prescription use. It includes storage instructions at 20° to 25°C and manufacturer details for Macleods Pharma USA, Inc. in Princeton, NJ, with the product made in India.*

FDA Label Image

456 (Milnacipran 50 60s)

Milnacipran Hydrochloride 50 mg film coated tablets label by Macleods Pharma USA, indicating 60 tablets per container. The label includes storage instructions, dispensing information, and manufacturer details for Macleods Pharmaceuticals Ltd, India. The NDC number 33342-371-09 is featured prominently.*

FDA Label Image

Fig-1 (Milnacipran Fig 1)

A line graph comparing the percent improvement in pain from baseline against the percent of patients improved for three groups: placebo, Milnacipran 100 mg, and Milnacipran 200 mg. The x-axis represents percent improvement in pain, and the y-axis indicates the percent of patients improved, showing trends for each group across the range of improvements.*

FDA Label Image

Fig-2 (Milnacipran Fig 2)

A line graph comparing the percent improvement in pain from baseline versus the percent of patients improved for a placebo group and two Milnacipran Hydrochloride groups at 100 mg and 200 mg dosages. The graph shows a downward trend for all groups as improvement percentage increases, with the 200 mg group generally indicating higher patient improvement than the 100 mg and placebo groups.*

FDA Label Image

Str (Milnacipran Str)

Chemical structure of Milnacipran Hydrochloride showing its molecular connectivity including a phenyl ring, cyclopropane ring, amine group, and hydrochloride component as depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.